Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 563 of 5804
-
New drug aims to shrink hard-to-treat HER2 cancers
Disease control Recruiting nowPhase Ib: Explore the safety and tolerability of BL-M07D1 to further define RP2D in a variety of solid tumors, including locally advanced or metastatic urinary and gastrointestinal tumors. Phase II: To explore the efficacy of BL-M07D1 in patients with a variety of solid tumors in…
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a common diabetes drug help delay preterm birth in preeclampsia?
Disease control Recruiting nowPreterm preeclampsia is a severe condition for both the mother and the fetus. Currently, the only treatment available to stop disease progression is termination/delivery of the fetus and placenta. Therefore, preterm preeclampsia carries the highest rates of neonatal morbidity and…
Phase: PHASE3 • Sponsor: Lina Bergman • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Experimental enzyme shot aims to rescue kidneys in sepsis patients
Disease control CompletedThe purpose of this Ph2b study is to characterize the dose-response relationship and to evaluate the safety and efficacy of three different single doses of TIN816 in hospitalized adult participants in an intensive care setting with a diagnosis of sepsis-associated acute kidney in…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New vaccine V116 aims to shield vulnerable kids from pneumococcal disease
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to evaluate the safety, tolerability, and immunogenicity of V116 compared to PPSV23 in children and teenagers 2 through 17 years of age, who had completed routine pneumococcal vaccine as infants/toddlers. Researchers want to learn if V116 is as good a…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:00 UTC
-
New meningitis vaccine shows promise in vietnam trial
⭐️ VACCINE ⭐️ CompletedThe MEQ00074 study was a Phase III, open-label, single-center study aimed at describing the immunogenicity and safety of a single dose of investigational quadrivalent Meningococcal Polysaccharide (serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine (MenACYW conjugate vacc…
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 17:46 UTC
-
New hope for Hard-to-Treat lung cancer: targeted drug combo trial launches
Disease control Recruiting nowThe purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibitors as a monotherapy or combined with Standard(s) of Care (SOC) or with each other. The first four subprotocols include t…
Phase: PHASE1, PHASE2 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Blood test could spot colon cancer early – 12,000 volunteers needed
Diagnosis Recruiting nowTo evaluate the performance characteristics of Signal-C™ a plasma circulating free-DNA test, to detect colorectal cancer and advanced precancerous lesions (APL) in an average risk screening population for 45 and over.
Sponsor: Universal Diagnostics • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
New stent shows promise in sealing brain aneurysms
Disease control CompletedThe primary objective of this trial is to evaluate the safety and efficacy of SINOMED IAS in patients with intracranial aneurysms.
Phase: NA • Sponsor: Sinomed Neurovita Technology Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a kidney drug be the next breakthrough for heart failure?
Disease control Recruiting nowFinerenone will be compared to placebo to determine efficacy and safety of treatment in patients hospitalized with acute decompensated heart failure (HF) and mildly reduced or preserved left ventricular ejection fraction.
Phase: PHASE3 • Sponsor: Colorado Prevention Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Promising drug combo aims to shrink breast tumors before surgery
Disease control OngoingThis is a multi-center, open-lable, prospective, randomized phase III clinical trial to further validate the efficacy and safety of neoadjuvant pyrotinib combined with chemotherapy in HR-positive/HER2-low (IHC 2+/FISH-negative) high-risk early breast cancer
Phase: PHASE3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New scan could spot hidden cancers faster and more accurately
Diagnosis Recruiting nowThe goal of this clinical trial is to learn if \[68Ga\]Ga-FAPI-46 Total Body PET/CT can diagnose patients suffering from gastroesophageal cancer and pancreatic cancer. The investigators hope that \[68Ga\]Ga-FAPI-46 Total Body PET/CT can improve staging and treatment evaluation fo…
Phase: PHASE2 • Sponsor: Barbara Malene Fischer • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New obesity drug shows promise in japanese trial
Disease control CompletedThis study is open to adults who are at least 18 years old and have * a body mass index (BMI) of 35 kg/m² or more and at least one health problem related to their weight, or * a BMI of 27 kg/m² or more and at least two health problems related to their weight. People who have ei…
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Immunotherapy plus chemo shows promise for bile duct cancer in early trial
Disease control Recruiting nowTo find out if adding pembrolizumab to standard of care chemotherapy drugs (cisplatin and gemcitabine) will improve long-term response of intrahepatic cholangiocarcinoma after surgery, compared to treatment with surgery and standard chemotherapy alone.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New combo shot CagriSema takes on tirzepatide in diabetes showdown
Disease control CompletedThis study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigational medicine. Doctors may not yet prescribe CagriSema. CagriSema will be compared to a medicine called tirzepatide that doctors may…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Liver transplant offers new hope for incurable bile duct cancer
Disease control Recruiting nowLITALHICA is a prospective non-randomized study aimed at exploring the outcome of liver transplantation in selected patients with unresectable perihilar cholangiocarcinoma (pCCA) after treatment with standard of care chemotherapy, in terms of overall survival and quality of life.…
Phase: NA • Sponsor: Azienda Sanitaria Ospedaliera • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Mothers and daughters join forces to fight HPV in nigeria
Prevention CompletedIn the current pilot study, Actions for Collaborative Community-Engaged Strategies for HPV (ACCESS-HPV), investigators will use participatory crowdsourcing methods to drive HPV prevention among mother-daughter dyads. Crowdsourcing open calls will allow us to identify locally rele…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Could an egg powder boost survival in brain cancer?
Disease control Recruiting nowThis is a randomised, double blinded and multiple center , Phase 2 study in patients with newly diagnosed glioblastoma. Participants will receive an egg powder enriched for antisecretory factor (AF), Salovum, or a placebo egg powder daily from 2 days before concomitant radio-chem…
Phase: PHASE2, PHASE3 • Sponsor: Peter Siesjö • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New vaccine aims to protect african children from deadly salmonella
⭐️ VACCINE ⭐️ OngoingThe purpose of this study is to evaluate the safety, reactogenicity, and immune response of the GlaxoSmithKline (GSK) Vaccines Institute for Global Health (GVGH) invasive nontyphoidal Salmonella-generalized modules for membrane antigens (iNTS-GMMA) candidate vaccine against S. Ty…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:35 UTC
-
Texting to stop HIV: 5,000 teens join landmark prevention study
Prevention Recruiting nowSHAG is a text messaging-based HIV prevention program designed for cisgender sexual minority boys and men 13-20 years of age across the United States. Investigators will test it against a control group that receives messages about healthy lifestyle.
Phase: NA • Sponsor: Center for Innovative Public Health Research • Aim: Prevention
Last updated Jul 11, 2026 00:00 UTC
-
Custom mRNA vaccine takes on rare endocrine cancers
Disease control Recruiting nowTreatment of advanced endocrine tumors, including adrenal corticocarcnioma (ACC), medullary thyroid carcinoma (MTC), thymic neuroendocrine tumor and pancreatic neuroendocrine tumor is challenging. Previous genomic profiling studies showed they presented a number of somatic mutati…
Phase: NA • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC